7
1
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T2382 | Vemurafenib | RO5185426,RG7204,PLX4032 | Raf , MAPK , ACK , Src , Autophagy |
Vemurafenib (RG7204) is a B-RAF inhibitor that inhibits RAFV600E and c-RAF-1 (IC50=31/48 nM) selectively and potently. Vemurafenib exhibits antitumor activity and is used for the treatment of BRAF V600E mutation-positive... | |||
T8654 | Plx-4032 | Vemurafenib | Raf |
Plx-4032 (Vemurafenib) is a small-molecule B-Raf inhibitor for the potential treatment of malignant melanoma. | |||
T27537 | Hexafluoro | ||
Hexafluoro is an inhibitor of DRP1 phosphorylation. Honokiol DCA stimulates a phenotype suggestive of respiration through mitochondrial normalization and demonstrates activity in Vemurafenib-resistant melanoma in vivo. | |||
T27551 | Honokiol DCA | Honokiol Bis-Dichloroacetate | |
Honokiol DCA is an inhibitor of DRP1 phosphorylation. Honokiol DCA stimulates a phenotype suggestive of respiration through mitochondrial normalization and demonstrating activity in Vemurafenib-resistant melanoma in vivo... | |||
T70424 | EBI-907 | ||
EBI-907 is a highly potent and orally efficacious B-RafV600E inhibitor. EBI-907 displays a low single-digit nanomolar activity (IC50 = 4.9 nM), which is >10-fold more potent than Vemurafenib (IC50 = 59 nM). EBI-907 also... | |||
T78777 | Vem-L-Cy5 | Raf | |
Vem-L-Cy5 (compound 3), a Vemurafenib-based BRAF inhibitor conjugated with the near-infrared (NIR) fluorophore cyanine-5 (Cy5), selectively targets the BRAF V600E mutation and inhibits MEK phosphorylation. This compound ... | |||
T63210 | Everafenib | ||
Everafenib is a potent BRAF inhibitor that crosses the blood-brain barrier and also inhibits the MAPK pathway. Everafenib inhibits the activity of a range of V600EBRAF melanoma cell lines (IC50: 2-10 nM) and is more effe... |
Cat No. | Product Name | ||
---|---|---|---|
L8800 | Drug-Fragment Library | 1158 compounds | |
1158 drug fragments,a must-have tool for FBDD; |